[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349994-105":59,"doc-detail-349994-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","serum-uric-acid-to-hdl-cholesterol-ratio-predicts-all-cause-mortality-in-cancer-patients-based-on-nhanes-data-observational-study","Serum uric acid to HDL-cholesterol ratio predicts all-cause mortality in cancer patients based on NHANES data - Observational Study","","This study explores the relationship between serum uric acid to high-density lipoprotein-cholesterol ratio (UHR) and all-cause mortality among US cancer patients. Data from the 2005 to 2018 National Health and Nutrition Examination Survey, linked to National Death Index records until December 31, 2019, are analyzed. Multivariate Cox proportional hazards models, Kaplan–Meier curves by UHR quartiles, and restricted cubic splines assess overall and dose-response effects. Subgroup and sensitivity analyses evaluate age, sex, diabetes, hypertension, BMI, income-to-poverty ratio, and cancer type. Higher UHR predicts reduced survival and increased mortality risk.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/serum-uric-acid-to-hdl-cholesterol-ratio-predicts-all-cause-mortality-in-cancer-patients-based-on-nhanes-data-observational-study/349994/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/serum-uric-acid-to-hdl-cholesterol-ratio-predicts-all-cause-mortality-in-cancer-patients-based-on-nhanes-data-observational-study/349994.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the UHR represent in this study?","Question",{"text":113,"@type":114},"UHR refers to the serum uric acid to high-density lipoprotein-cholesterol ratio. The study evaluates whether this ratio predicts all-cause mortality in cancer patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which data sources and follow-up period are used?",{"text":118,"@type":114},"The analysis uses NHANES data from 2005–2018 linked to National Death Index records through December 31, 2019. Follow-up lasts 81.0 months.",{"name":120,"@type":111,"acceptedAnswer":121},"How do the findings relate higher UHR to mortality risk?",{"text":122,"@type":114},"Patients in the top UHR quartile show a significantly higher all-cause mortality risk versus others (hazard ratio 1.43, 95% CI 1.07–1.93). Kaplan–Meier analyses also link higher UHR with reduced survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349994,1790452337,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","®  \n Observational Study   \nSerum uric acid to HDL-cholesterol ratio predicts all-cause mortality in cancer patients based on NHANES data  \nJiaying Zhang, MSa , Dong Niu, MDa , Valery Smirnov, MDb , Jiahui Li, MSa , Vladimir I. Gegechkori, MDb , Hengzhou Zhu, MDc , Xiaodan Zhu, MDc , Chunhui Jin, MDc ,*  \n\n| Abstract\u003Cbr>This study explores the relationship between serum uric acid to high-density lipoprotein-cholesterol ratio (UHR) and all-cause mortality among US cancer patients. Data from the 2005 to 2018 National Health and Nutrition Examination Survey, linked to National Death Index records until December 31, 2019, are analyzed. To investigate the relationship between UHR and mortality, multivariate Cox proportional hazards models are utilized. Kaplan–Meier curves compare survival across UHR quartiles, while the restricted cubic spline approach evaluates dose-response relationships. Subgroup analyses consider age, gender, diabetes, hypertension, body mass index, and income-to-poverty ratio, with stratified analyses by cancer type. Two sensitivity analyses exclude participants under 65 and those with multiple cancers. During the 81.0-month follow-up period, the all-cause mortality rate is 15.6% . Cancer patients in the top quartile group have a significantly increased mortality risk (hazard ratio: 1.43, 95% confidence interval: 1.07–1.93) . Kaplan–Meier survival analysis links higher UHR to reduced survival. This association is nonlinear and more pronounced in those aged ≥ 65, males, and individuals with diabetes or hypertension. Stratified analyses reveal a significant link in breast, colorectal, and prostate cancers. UHR may serve as a valuable predictor of all-cause mortality among individuals with cancer. |\n| --- |\n| Abbreviations: BMI = body mass index, CI = confidence interval , CVD = cardiovascular diseases, FDR = false discovery rate, HDL-C = high-density lipoprotein-cholesterol, NHANES = National Health and Nutrition Examination Survey, OS = overall survival, PIR = income-to-poverty ratio, RCS = restricted cubic spline, UA = serum uric acid, UHR = serum uric acid to high-density lipoprotein-cholesterol ratio. |\n| Keywords: all-cause mortality, cancer, HDL-cholesterol ratio, NHANES, serum uric acid |\n\n1. Introduction  \nCancer is one of the leading causes of death worldwide. [1] Since 1990, the mortality rate among cancer patients has increased sharply, climbing from the 3rd to the 2nd most common cause of death by 2013, surpassed only by heart disease. [2] By the end of 2025, the United States is expected to report 2,041,910 new cases of cancer and 618,120 deaths from this disease. [3] Cancer is still a leading cause of high mortality rates, despite  \ntremendous progress in its prevention, diagnosis, and treatment. [4] Cancer sufferers face not only the physical pain and suffering brought on by the illness and its treatment, but also the financial burden of expensive medical costs. Identifying effective prognostic biomarkers early in the disease could help identify high-risk patients and enable targeted intervention strategies. This approach would not only alleviate healthcare costs and reduce patient suffering, but also improve treatment outcomes and significantly enhance overall survival (OS) rates  \nJZ, DN, and VS contributed to this article equally.  \nThe author(s) declare financial support was received for the research, authorship, and/or publication of this article. This article is supported by National Natural Science Foundation of China (82274269).  \nThe authors have no conflict of interest to disclose.  \nThe datasets generated during and/or analyzed during the current study are publicly available.  \nThe survey protocols were approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board. The ethical approval numbers for the NHANES survey cycles included in this analysis (2005–2018) are: Protocol  \n\\#2005-06, Protocol \\#2011-17, and Protocol \\#2018-01. All participants provided writ","cbCaivcRVDCQXmvM","https://ap.wps.com/l/cbCaivcRVDCQXmvM","pdf",927759,12,"English","# Abstract\n# Introduction\n## Background and rationale\n# Methods\n## Data source and study design\n## Statistical analysis\n# Results\n## Mortality association and survival analysis\n# Subgroup and sensitivity analyses\n# Discussion","[{\"question\":\"What does the UHR represent in this study?\",\"answer\":\"UHR refers to the serum uric acid to high-density lipoprotein-cholesterol ratio. The study evaluates whether this ratio predicts all-cause mortality in cancer patients.\"},{\"question\":\"Which data sources and follow-up period are used?\",\"answer\":\"The analysis uses NHANES data from 2005–2018 linked to National Death Index records through December 31, 2019. Follow-up lasts 81.0 months.\"},{\"question\":\"How do the findings relate higher UHR to mortality risk?\",\"answer\":\"Patients in the top UHR quartile show a significantly higher all-cause mortality risk versus others (hazard ratio 1.43, 95% CI 1.07–1.93). Kaplan–Meier analyses also link higher UHR with reduced survival.\"}]","Serum uric acid to HDL-cholesterol ratio predicts all-cause mortality in cancer patients based on NHANES data - Observational Study | PDF",1790086647,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2d330400ef0eb76434f95a937c5650d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e0f7218425de16c8f7840ea422e5994.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/391daad62d605f26137de38907cd4854.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4c5b049b8200c936e54db808348f84c.webp",980,1306]